Skip to main content

Table 4 Incidence of fracture according to type of renin-angiotensin system inhibitor

From: The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study

Variables

Fracture case

Controls

Conditional logistic regression

(n = 1,049)

(n = 1,049)

n

%

n

%

OR (95% CI)

P-value

RASi use

Never-user

819

51.3

778

48.7

  

ARB only-user

126

44.1

160

55.9

0.65 (0.49–0.86)

0.003

ACEi only-user

51

47.7

56

52.3

0.85 (0.55–1.30)

0.447

ARB/ACEi-ever user

53

49.1

55

50.9

0.82 (0.54–1.26)

0.369

  1. Abbreviations: RASi Renin-angiotensin system inhibitors, ARB Angiotensin II receptor blocker, ACEi As angiotensin converting enzyme inhibitor